Zhejiang Esigma Biotechnology Co., Ltd. is a high-tech enterprise focusing on R&D, production, sales and service of feed medicinal additives (from raw materials to preparations). Its core business is to improve animal health and growth performance by enhancing feed efficiency, through the innovative application of fine chemicals, bio-fermentation, and animal Antibiotics.

Founded in 1997 by Dr. Chen Guicai, a Harvard postdoctoral researcher, Esigma has a total of over 33,333 square meters (50 mu) of production bases covering fine chemicals, bio-fermentation, and animal health care. It has registered over 40 trademarks including Esigma and NONON, and holds more than 50 national invention patents. The company has been awarded titles such as "National High-Tech Enterprise", "Zhejiang Patent Demonstration Enterprise", and "Zhejiang Innovative Indicator Enterprise", and has been recognized as the vice-chairman unit of multiple industry associations.

Esigma's core product lines include Antibiotics and Coccidiostats. Among them, NONON (Nosiheptide) leads the global market in both production and sales, while its coccidiostats maintain a leading market share in China. Over the past 28 years, Esigma's products have been sold well in more than 30 provinces/municipalities in China and exported to over 40 countries worldwide. With GMP certifications from China and Australia, the company has established long-term stable partnerships with renowned enterprises such as Chia Tai Group, Cargill, and New Hope Group.

The stable development of Esigma is inseparable from the support of all sectors of society and the full cooperation of the Esigma team. We believe that focusing on product R&D, pursuing superior quality, and meeting customer needs are the three cornerstones of Esigma's success. The Esigma R&D Team has undertaken national 863 Projects and presided over key scientific and technological research projects in Zhejiang Province. As the first completing unit, the company has won the "Zhejiang Provincial Science and Technology First-Class Award" and the "National Key New Product Certificate". All enterprise standards for Esigma's products exceed the national standards, and products are strictly manufactured in accordance with GMP requirements, ensuring customers' confidence in quality.

Beyond R&D excellence, Esigma prioritizes customer-centric services. For example, in the coccidiostat market, we provide customers with one-stop professional services—from the prediction of coccidiosis outbreaks and monitoring of coccidial oocysts to the development of optimal drug regimens.

"Honest and upright, people-oriented, dedicated and collaborative, pioneering and innovative" are the core values of Esigma. All Esigma employees will build the brand with quality and shape the future with the brand.